Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trials Not Allowed)
ID: 358892Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/358892
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support," aimed at providing operational support for NBLs located at the University of Texas Medical Branch in Galveston, Texas, and Boston University in Massachusetts. The funding will support essential services such as facility maintenance, biosecurity, environmental health and safety compliance, and specialized research support, which are critical for conducting research on hazardous biological agents in alignment with NIAID's biodefense and emerging infectious diseases initiatives. With an estimated total program funding of $23 million and the expectation of awarding two grants, interested organizations are encouraged to prepare for application submission, with the anticipated synopsis posting on September 11, 2025, and a closing date of November 10, 2025. For further inquiries, potential applicants can contact Fayna Diaz San Segundo at fayna.diazsansegundo@nih.gov or by phone at 240-921-3931.

    Point(s) of Contact
    Fayna Diaz San Segundo National Institute of Allergy and Infectious Diseases (NIAID)
    (240) 921-3931
    fayna.diazsansegundo@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Forecast for The NINDS Human Biospecimen and Data Repository (U24 - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to release a Notice of Funding Opportunity (NOFO) for the NINDS Human Biospecimen and Data Repository, aimed at advancing research in neurological disorders. This initiative will establish a repository to maintain and expand a collection of biospecimens, which will be made available to qualified academic and industry researchers to support basic, translational, and clinical research efforts. The total estimated funding for this program is $1,950,000, with one award anticipated, and interested applicants are encouraged to begin forming collaborations and developing proposals ahead of the expected synopsis posting on August 25, 2025. For further inquiries, potential applicants can contact Dr. Rebecca Price at rebecca.price@nih.gov or by phone at 301-827-3587.
    Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the development of Collaborative Research Facilities or Research-Resource Facilities through a federal grant opportunity titled "Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not Allowed)." This initiative aims to fund the construction or modernization of shared-use biomedical research facilities that will enhance research capabilities, promote interdisciplinary collaboration, and address emerging health concerns, particularly in the areas of HIV/AIDS and other biomedical fields. With an estimated total program funding of $88 million and the expectation of awarding 12 grants, interested private institutions of higher education are encouraged to apply. Key deadlines include the estimated synopsis post date on July 28, 2025, and the application close date on January 25, 2026. For further inquiries, applicants can contact Xiang-Ning Li, MD, PhD, at xiang-ning.li@nih.gov or by phone at 301-435-1744.
    Tuberculosis Research Units (P01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity for the establishment of multidisciplinary Tuberculosis Research Units (TBRUs) through a grant program aimed at enhancing the understanding of Mycobacterium tuberculosis (Mtb) and its interactions with the host. This initiative seeks to foster collaborative research that characterizes the roles of bacterial and host heterogeneity in infection outcomes and disease progression, with a focus on identifying determinants relevant to Mtb establishment and dissemination. The total estimated program funding is $10 million, with approximately five awards expected, and interested applicants are encouraged to begin forming collaborations in anticipation of the Notice of Funding Opportunity (NOFO) expected to be published in September 2025. For further inquiries, potential applicants can contact Richard T. Robinson, Ph.D., at richard.robinson@nih.gov or by phone at 202-607-8565.
    NIAID Resource-Related Research Projects
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "NIAID Resource-Related Research Projects," aimed at supporting investigator-initiated research that develops essential resources for biomedical research. This program encourages small businesses to propose non-hypothesis-driven activities that provide high-quality data, materials, tools, or services relevant to the NIAID mission, which includes areas such as infectious diseases, immune function, and translational research for vaccines and therapeutics. Interested applicants should note that there is no cost-sharing requirement, and the estimated synopsis close date is January 26, 2026, with awards expected to be made by December 1, 2026. For further inquiries, applicants can contact Dr. Chelsea Boyd at chelsea.boyd@nih.gov or by phone at 301-761-6664.
    NIGMS National and Regional Resources
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "NIGMS National and Regional Resources," aimed at supporting resources that enhance biomedical research capabilities for a large number of investigators. This program seeks to provide access to state-of-the-art technologies and expertise, enabling substantial numbers of researchers to benefit from resources that may not be available at individual institutions. The grant is open to small businesses, with no cost-sharing or matching requirements, and is categorized under discretionary funding with an estimated award date of June 1, 2026. Interested applicants can reach out to Han Nguyen, Ph.D., at han.nguyen@nih.gov or call 301-594-4640 for further information, and should note that the application period will close on September 25, 2025.
    Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a forthcoming funding opportunity titled "Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed)" aimed at supporting the development, production, and distribution of nonhuman primate-specific immunologic reagents. This initiative, led by the National Institute of Allergy and Infectious Diseases (NIAID), seeks to enhance preclinical research in nonhuman primate models to accelerate advancements in cures, vaccines, and treatments for immune-mediated diseases and emerging infectious diseases. The estimated total program funding is $1,300,000, with one award expected, and applications are anticipated to be solicited starting in late August 2025, with a closing date in late October 2025. Interested applicants can reach out to Dr. Shilpa Kulkarni at shilpa.kulkarni@nih.gov or call 240-747-7365 for further information.
    Forecast to Publish a Notice of Funding Opportunity for The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Laboratory (U24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the establishment of a Pharmacokinetics Resource Laboratory (PK Laboratory) to support the Experimental Therapeutics Clinical Trials Network (ETCTN). This initiative aims to solicit applications from private institutions of higher education to maintain or establish a laboratory that will facilitate biospecimen collections and analyze pharmacokinetic endpoints, drug-drug interactions, and other critical factors in clinical trials involving NCI Investigational New Drug (IND) agents. The PK Laboratory is essential for advancing the clinical development of these agents and will require a multidisciplinary approach, including technical services, scientific leadership, and biospecimen management. The estimated total program funding is $850,000, with one award anticipated, and the NOFO is expected to be published in Summer 2025, with applications due in Fall 2025. For further inquiries, interested parties can contact Dr. Lori A. Henderson at NCIETCTNRFA@mail.nih.gov or by phone at 240-276-5930.
    Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to announce a funding opportunity for the Animal and Biological Material Resource Centers under the P40 grant mechanism, aimed at supporting projects that develop and maintain animal models and related biological resources. This initiative seeks to enhance the scientific rigor and reproducibility of biomedical research by providing accessible resources, including special colonies of laboratory animals, informatics tools, and new approach methodologies (NAMs) that complement traditional animal-based research. With an estimated total program funding of $1,300,000 and the expectation of awarding two grants, interested small businesses should prepare for the application process, which will open in December 2025, with submissions due by February 2026. For further inquiries, potential applicants can contact Oleg Mirochnitchenko, PhD, at Oleg.mirochnitchenko@nih.gov or by phone at 301-435-0748.
    Effectively Strengthening Safety and Security of Biological Research Globally
    Bureau of International Security-Nonproliferation
    The Bureau of International Security-Nonproliferation is offering a federal grant titled "Effectively Strengthening Safety and Security of Biological Research Globally," aimed at enhancing global biosafety and biosecurity in alignment with the Biological Weapons Convention (BWC). This initiative seeks to bolster the capabilities of various countries, particularly in areas such as improving operations at high-containment laboratories, enhancing oversight of pathogen research, and promoting best practices for biological risk management. With a total funding amount of $2 million available for a 24-month performance period, eligible applicants include U.S.-based organizations and foreign entities, with proposals due by August 11, 2025. Interested parties can reach out to the Biological Policy Staff at ISN-BPS-DL@STATE.GOV for further information and guidance on the application process.
    International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)" aimed at supporting research on infectious diseases in resource-constrained countries. This initiative encourages applications from organizations based in low- and lower-middle-income economies, as classified by the World Bank, and seeks innovative proposals addressing diseases such as HIV/AIDS, tuberculosis, and malaria, with a focus on enhancing local scientific capacity. The total funding available for fiscal year 2024 is approximately $1,360,000, with individual project budgets capped at $125,000 per year for a maximum of five years. Interested applicants can find more information and submission guidelines at the NIH website, with applications accepted until August 1, 2025.